TRACON Pharma Q1 EPS $(1.33) Misses $(1.19) Estimate, Sales $100.00K
Portfolio Pulse from Benzinga Newsdesk
TRACON Pharma (NASDAQ:TCON) reported Q1 EPS of $(1.33), missing the $(1.19) estimate, marking a 269.44% increase in losses from last year. Sales reached $100.00K.

May 14, 2024 | 8:06 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
TRACON Pharma's Q1 earnings missed estimates with a significant increase in losses compared to last year, alongside modest sales.
Missing the EPS estimate and reporting a substantial increase in losses year-over-year are negative indicators for investor sentiment and could lead to a short-term decrease in stock price. The reported sales, while modest, are unlikely to offset the negative impact of the earnings miss and increased losses.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100